

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 6.04640987 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 5.95888712 |
| 3 | fatty acid transmembrane transport (GO:1902001) | 5.45175652 |
| 4 | valine metabolic process (GO:0006573) | 5.29035416 |
| 5 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.04296934 |
| 6 | carnitine shuttle (GO:0006853) | 5.01118285 |
| 7 | biotin metabolic process (GO:0006768) | 5.00219684 |
| 8 | triglyceride catabolic process (GO:0019433) | 4.87818257 |
| 9 | positive regulation of fatty acid oxidation (GO:0046321) | 4.84526567 |
| 10 | fatty acid beta-oxidation (GO:0006635) | 4.84385361 |
| 11 | neutral lipid catabolic process (GO:0046461) | 4.49093888 |
| 12 | acylglycerol catabolic process (GO:0046464) | 4.49093888 |
| 13 | brown fat cell differentiation (GO:0050873) | 4.45303911 |
| 14 | fatty acid oxidation (GO:0019395) | 4.38044944 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.33142173 |
| 16 | lipid oxidation (GO:0034440) | 4.29548772 |
| 17 | endothelium development (GO:0003158) | 4.22883606 |
| 18 | fatty acid catabolic process (GO:0009062) | 4.15582385 |
| 19 | carnitine transmembrane transport (GO:1902603) | 4.06021157 |
| 20 | white fat cell differentiation (GO:0050872) | 4.05514907 |
| 21 | regulation of fatty acid oxidation (GO:0046320) | 4.05004542 |
| 22 | amino-acid betaine transport (GO:0015838) | 4.00708464 |
| 23 | carnitine transport (GO:0015879) | 4.00708464 |
| 24 | branched-chain amino acid metabolic process (GO:0009081) | 3.97718303 |
| 25 | lysine catabolic process (GO:0006554) | 3.90533560 |
| 26 | lysine metabolic process (GO:0006553) | 3.90533560 |
| 27 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.90295613 |
| 28 | branched-chain amino acid catabolic process (GO:0009083) | 3.87975302 |
| 29 | regulation of cholesterol storage (GO:0010885) | 3.86420171 |
| 30 | 2-oxoglutarate metabolic process (GO:0006103) | 3.85149394 |
| 31 | * retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.85033558 |
| 32 | acetyl-CoA metabolic process (GO:0006084) | 3.78034781 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.77004282 |
| 34 | ovulation from ovarian follicle (GO:0001542) | 3.70106231 |
| 35 | lymphangiogenesis (GO:0001946) | 3.66665612 |
| 36 | positive regulation of lipid catabolic process (GO:0050996) | 3.59398343 |
| 37 | plasma lipoprotein particle clearance (GO:0034381) | 3.58852549 |
| 38 | monocarboxylic acid catabolic process (GO:0072329) | 3.55578962 |
| 39 | tricarboxylic acid metabolic process (GO:0072350) | 3.53241416 |
| 40 | complement activation, alternative pathway (GO:0006957) | 3.53074404 |
| 41 | blood vessel maturation (GO:0001955) | 3.52397246 |
| 42 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.49614339 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 3.46617052 |
| 44 | quaternary ammonium group transport (GO:0015697) | 3.45747198 |
| 45 | fatty acid homeostasis (GO:0055089) | 3.44277493 |
| 46 | lipid particle organization (GO:0034389) | 3.43934944 |
| 47 | diacylglycerol metabolic process (GO:0046339) | 3.42518963 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 3.41567724 |
| 49 | triglyceride biosynthetic process (GO:0019432) | 3.36703541 |
| 50 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.31984032 |
| 51 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.31641734 |
| 52 | acylglycerol biosynthetic process (GO:0046463) | 3.31489251 |
| 53 | neutral lipid biosynthetic process (GO:0046460) | 3.31489251 |
| 54 | transcytosis (GO:0045056) | 3.29711322 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.29305310 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.29305310 |
| 57 | ethanol oxidation (GO:0006069) | 3.23426823 |
| 58 | tricarboxylic acid cycle (GO:0006099) | 3.23159864 |
| 59 | triglyceride metabolic process (GO:0006641) | 3.22031876 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.18990121 |
| 61 | intracellular lipid transport (GO:0032365) | 3.17372034 |
| 62 | glycerolipid catabolic process (GO:0046503) | 3.16782225 |
| 63 | oxaloacetate metabolic process (GO:0006107) | 3.15000008 |
| 64 | carnitine metabolic process (GO:0009437) | 3.14955751 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.13799443 |
| 66 | glomerular filtration (GO:0003094) | 3.13631331 |
| 67 | acyl-CoA biosynthetic process (GO:0071616) | 3.10264711 |
| 68 | thioester biosynthetic process (GO:0035384) | 3.10264711 |
| 69 | L-phenylalanine catabolic process (GO:0006559) | 3.10194331 |
| 70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.10194331 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.09949458 |
| 72 | lipid storage (GO:0019915) | 3.06834769 |
| 73 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06012804 |
| 74 | acylglycerol metabolic process (GO:0006639) | 3.04086970 |
| 75 | positive regulation of lipid storage (GO:0010884) | 3.03974590 |
| 76 | growth hormone receptor signaling pathway (GO:0060396) | 3.03775291 |
| 77 | NADH metabolic process (GO:0006734) | 3.03194328 |
| 78 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02803362 |
| 79 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.01595578 |
| 80 | L-phenylalanine metabolic process (GO:0006558) | 3.01595578 |
| 81 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.00028074 |
| 82 | lymph vessel development (GO:0001945) | 2.99603666 |
| 83 | neutral lipid metabolic process (GO:0006638) | 2.98532336 |
| 84 | regulation of plasminogen activation (GO:0010755) | 2.96436073 |
| 85 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.95477424 |
| 86 | regulation of lipoprotein metabolic process (GO:0050746) | 2.94233051 |
| 87 | positive regulation of glomerulus development (GO:0090193) | 2.93767788 |
| 88 | basement membrane organization (GO:0071711) | 2.90232116 |
| 89 | negative regulation of protein autophosphorylation (GO:0031953) | 2.90022076 |
| 90 | succinate metabolic process (GO:0006105) | 2.87997691 |
| 91 | negative regulation of fatty acid transport (GO:2000192) | 2.86965843 |
| 92 | renal filtration (GO:0097205) | 2.86198163 |
| 93 | epoxygenase P450 pathway (GO:0019373) | 2.86072994 |
| 94 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.85611950 |
| 95 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.84939504 |
| 96 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.83669836 |
| 97 | phospholipid homeostasis (GO:0055091) | 2.83162486 |
| 98 | endothelial cell morphogenesis (GO:0001886) | 2.83110220 |
| 99 | homocysteine metabolic process (GO:0050667) | 2.82509747 |
| 100 | cysteine metabolic process (GO:0006534) | 2.81949886 |
| 101 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.79860247 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.79746860 |
| 103 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.77964479 |
| 104 | protein carboxylation (GO:0018214) | 2.77218620 |
| 105 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.77218620 |
| 106 | apoptotic cell clearance (GO:0043277) | 2.76906935 |
| 107 | polyol transport (GO:0015791) | 2.75643898 |
| 108 | coenzyme A biosynthetic process (GO:0015937) | 2.75300630 |
| 109 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.73759890 |
| 110 | glyoxylate metabolic process (GO:0046487) | 2.72096325 |
| 111 | negative regulation of lipase activity (GO:0060192) | 2.71777350 |
| 112 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.70993145 |
| 113 | regulation of triglyceride metabolic process (GO:0090207) | 2.70649202 |
| 114 | cellular response to epinephrine stimulus (GO:0071872) | 2.69426418 |
| 115 | protein heterotrimerization (GO:0070208) | 2.68819587 |
| 116 | carboxylic acid catabolic process (GO:0046395) | 2.67691736 |
| 117 | organic acid catabolic process (GO:0016054) | 2.67691736 |
| 118 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.67659649 |
| 119 | response to dietary excess (GO:0002021) | 2.66671242 |
| 120 | positive regulation of glycolytic process (GO:0045821) | 2.66129281 |
| 121 | long-chain fatty acid transport (GO:0015909) | 2.66010607 |
| 122 | blood coagulation, intrinsic pathway (GO:0007597) | 2.65403781 |
| 123 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.64639244 |
| 124 | acyl-CoA metabolic process (GO:0006637) | 2.63605566 |
| 125 | regulation of protein activation cascade (GO:2000257) | 2.63533812 |
| 126 | regulation of complement activation (GO:0030449) | 2.60411078 |
| 127 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.59986274 |
| 128 | regulation of fibrinolysis (GO:0051917) | 2.59838998 |
| 129 | protein localization to cell surface (GO:0034394) | 2.59820448 |
| 130 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.58977218 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.58977218 |
| 132 | ethanol metabolic process (GO:0006067) | 2.54502957 |
| 133 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.53501078 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 2.48208713 |
| 135 | macromolecular complex remodeling (GO:0034367) | 2.48208713 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 2.48208713 |
| 137 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46527705 |
| 138 | response to epinephrine (GO:0071871) | 2.45770503 |
| 139 | regulation of cholesterol esterification (GO:0010872) | 2.45507205 |
| 140 | cell migration involved in heart development (GO:0060973) | 2.43393826 |
| 141 | positive regulation of glucose import (GO:0046326) | 2.43171809 |
| 142 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.42539461 |
| 143 | cardiac myofibril assembly (GO:0055003) | 2.40991001 |
| 144 | response to phenylpropanoid (GO:0080184) | 2.39040502 |
| 145 | negative regulation of protein activation cascade (GO:2000258) | 2.37582111 |
| 146 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.35460215 |
| 147 | cell proliferation involved in metanephros development (GO:0072203) | 2.32957535 |
| 148 | negative regulation of metanephros development (GO:0072217) | 2.28895331 |
| 149 | endocardial cushion development (GO:0003197) | 2.28089801 |
| 150 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.28058947 |
| 151 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.27409869 |
| 152 | positive regulation of cholesterol efflux (GO:0010875) | 2.26862358 |
| 153 | regulation of apoptotic cell clearance (GO:2000425) | 2.26469137 |
| 154 | negative regulation of cartilage development (GO:0061037) | 2.26417988 |
| 155 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.26270501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.71906152 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.28331505 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.43858547 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21947506 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.93455731 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77169024 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.54892520 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.95746372 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.74659055 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61835040 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32210283 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.98545889 |
| 13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.98523088 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96303216 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90071562 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.88090639 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78990196 |
| 18 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.73987455 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70126004 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67427865 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.64709393 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.64709393 |
| 23 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.64254389 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63226815 |
| 25 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57068999 |
| 26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55440578 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51566418 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49934332 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48221353 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48179974 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47172535 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42311302 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.39647227 |
| 34 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37867841 |
| 35 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.37599531 |
| 36 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.37538505 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35675790 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33984357 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28294287 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.26873942 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24117804 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21654198 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20788395 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20710497 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.19847758 |
| 46 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19691622 |
| 47 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18418745 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16244959 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.14774484 |
| 50 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14545671 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13371698 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12845235 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12845235 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11267880 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10078211 |
| 56 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06734443 |
| 57 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06351341 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03972147 |
| 59 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00858736 |
| 60 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00281041 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98339657 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95873285 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95369312 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94771970 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94308846 |
| 66 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93860377 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92103982 |
| 68 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91841698 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91391635 |
| 70 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91107935 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90434896 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90027049 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88687131 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88116333 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87741244 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87605312 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87389104 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86723725 |
| 79 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85518089 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85392157 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85169007 |
| 82 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85140651 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84802176 |
| 84 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.84581526 |
| 85 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.84581526 |
| 86 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.84581526 |
| 87 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83767915 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83744590 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83732667 |
| 90 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83616419 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83257180 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.83190899 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81759425 |
| 94 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81751489 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80680772 |
| 96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80601746 |
| 97 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80412442 |
| 98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79846375 |
| 99 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79764812 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79398042 |
| 101 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79196399 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78079829 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.78064034 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77430461 |
| 105 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76473204 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76353673 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75408240 |
| 108 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.73938648 |
| 109 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.73938648 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73274947 |
| 111 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.72202365 |
| 112 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71421140 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70634395 |
| 114 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.70211806 |
| 115 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.70051414 |
| 116 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69455950 |
| 117 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.69252180 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68110670 |
| 119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.67493279 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.67406703 |
| 121 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.67066052 |
| 122 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.66658387 |
| 123 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.66282469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.24993390 |
| 2 | MP0005666_abnormal_adipose_tissue | 3.81249954 |
| 3 | MP0004130_abnormal_muscle_cell | 3.77900552 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.41424284 |
| 5 | MP0005360_urolithiasis | 3.24531328 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.18600622 |
| 7 | MP0004185_abnormal_adipocyte_glucose | 3.04978083 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.04379564 |
| 9 | MP0005375_adipose_tissue_phenotype | 2.80874776 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.70444291 |
| 11 | MP0005365_abnormal_bile_salt | 2.68565195 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.67557520 |
| 13 | MP0004272_abnormal_basement_membrane | 2.58540454 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.57539570 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.49497579 |
| 16 | MP0002971_abnormal_brown_adipose | 2.32321280 |
| 17 | MP0005275_abnormal_skin_tensile | 2.32151228 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 2.24770604 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.23622271 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.17586469 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.04871083 |
| 22 | MP0000003_abnormal_adipose_tissue | 2.00999487 |
| 23 | MP0003868_abnormal_feces_composition | 1.94012337 |
| 24 | MP0000751_myopathy | 1.83853465 |
| 25 | MP0003252_abnormal_bile_duct | 1.80976211 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.80513358 |
| 27 | MP0009115_abnormal_fat_cell | 1.80427991 |
| 28 | MP0003941_abnormal_skin_development | 1.63783895 |
| 29 | MP0005334_abnormal_fat_pad | 1.62896478 |
| 30 | MP0005332_abnormal_amino_acid | 1.62651442 |
| 31 | MP0003828_pulmonary_edema | 1.62613706 |
| 32 | MP0003646_muscle_fatigue | 1.59434874 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.56978936 |
| 34 | MP0003724_increased_susceptibility_to | 1.55451045 |
| 35 | MP0006138_congestive_heart_failure | 1.55279555 |
| 36 | MP0001661_extended_life_span | 1.52636865 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.52313789 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.49674477 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.48783966 |
| 40 | MP0005330_cardiomyopathy | 1.40426246 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.39853930 |
| 42 | MP0000609_abnormal_liver_physiology | 1.38695355 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.35385298 |
| 44 | MP0005620_abnormal_muscle_contractility | 1.34148102 |
| 45 | MP0005409_darkened_coat_color | 1.32111277 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.32053486 |
| 47 | MP0005535_abnormal_body_temperature | 1.29465358 |
| 48 | MP0005385_cardiovascular_system_phenoty | 1.28614835 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 1.28614835 |
| 50 | MP0002970_abnormal_white_adipose | 1.25657576 |
| 51 | MP0003011_delayed_dark_adaptation | 1.25248842 |
| 52 | * MP0004087_abnormal_muscle_fiber | 1.22168565 |
| 53 | MP0006054_spinal_hemorrhage | 1.18211485 |
| 54 | MP0001958_emphysema | 1.18119869 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.17993624 |
| 56 | MP0000750_abnormal_muscle_regeneration | 1.17927406 |
| 57 | MP0004147_increased_porphyrin_level | 1.17891186 |
| 58 | MP0002933_joint_inflammation | 1.15461835 |
| 59 | MP0002972_abnormal_cardiac_muscle | 1.15375341 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.15235853 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.15123897 |
| 62 | MP0003186_abnormal_redox_activity | 1.14769701 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.14190179 |
| 64 | MP0001756_abnormal_urination | 1.14022603 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.13955366 |
| 66 | MP0000749_muscle_degeneration | 1.10384989 |
| 67 | MP0003959_abnormal_lean_body | 1.09324415 |
| 68 | * MP0002128_abnormal_blood_circulation | 1.08367899 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.07858864 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.03788021 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.03407225 |
| 72 | MP0003279_aneurysm | 1.02823542 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.01197360 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.99416910 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.98944312 |
| 76 | * MP0001614_abnormal_blood_vessel | 0.98096718 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.97869456 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96788634 |
| 79 | MP0002108_abnormal_muscle_morphology | 0.95979122 |
| 80 | MP0000343_altered_response_to | 0.95727951 |
| 81 | MP0001915_intracranial_hemorrhage | 0.95445790 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.95041923 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.92758409 |
| 84 | MP0003091_abnormal_cell_migration | 0.91907406 |
| 85 | MP0004484_altered_response_of | 0.86263905 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.85405328 |
| 87 | * MP0000759_abnormal_skeletal_muscle | 0.84654845 |
| 88 | MP0002295_abnormal_pulmonary_circulatio | 0.83655097 |
| 89 | MP0003045_fibrosis | 0.83299649 |
| 90 | MP0005448_abnormal_energy_balance | 0.82493456 |
| 91 | MP0003385_abnormal_body_wall | 0.82325335 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.82308224 |
| 93 | MP0005023_abnormal_wound_healing | 0.80481533 |
| 94 | MP0004043_abnormal_pH_regulation | 0.79272536 |
| 95 | MP0000266_abnormal_heart_morphology | 0.78722961 |
| 96 | MP0000733_abnormal_muscle_development | 0.78594129 |
| 97 | * MP0002925_abnormal_cardiovascular_devel | 0.78302460 |
| 98 | MP0004233_abnormal_muscle_weight | 0.78180893 |
| 99 | MP0002168_other_aberrant_phenotype | 0.77703901 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.77308885 |
| 101 | MP0005503_abnormal_tendon_morphology | 0.77030025 |
| 102 | MP0002106_abnormal_muscle_physiology | 0.76893598 |
| 103 | MP0002060_abnormal_skin_morphology | 0.76516827 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.76458996 |
| 105 | MP0004085_abnormal_heartbeat | 0.76417421 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.75677195 |
| 107 | MP0003195_calcinosis | 0.75134715 |
| 108 | MP0001666_abnormal_nutrient_absorption | 0.74572675 |
| 109 | MP0000534_abnormal_ureter_morphology | 0.73895614 |
| 110 | MP0002796_impaired_skin_barrier | 0.73057488 |
| 111 | MP0005452_abnormal_adipose_tissue | 0.72603400 |
| 112 | MP0005595_abnormal_vascular_smooth | 0.72273741 |
| 113 | MP0005369_muscle_phenotype | 0.71504932 |
| 114 | MP0000249_abnormal_blood_vessel | 0.71498310 |
| 115 | MP0002269_muscular_atrophy | 0.71376242 |
| 116 | MP0003948_abnormal_gas_homeostasis | 0.71070790 |
| 117 | MP0001764_abnormal_homeostasis | 0.70160723 |
| 118 | MP0005164_abnormal_response_to | 0.69563972 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.68902422 |
| 120 | MP0000747_muscle_weakness | 0.68205535 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.67766268 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.66914610 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65476620 |
| 124 | MP0005165_increased_susceptibility_to | 0.65271859 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.65065843 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.64740345 |
| 127 | MP0000163_abnormal_cartilage_morphology | 0.64464878 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.63354279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 4.93271823 |
| 2 | Oligomenorrhea (HP:0000876) | 4.46023558 |
| 3 | Acanthosis nigricans (HP:0000956) | 4.17567483 |
| 4 | Abnormality of glycine metabolism (HP:0010895) | 4.17290910 |
| 5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.17290910 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.06290955 |
| 7 | Myoglobinuria (HP:0002913) | 3.99709318 |
| 8 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.92263297 |
| 9 | Ketoacidosis (HP:0001993) | 3.76595869 |
| 10 | Hypertriglyceridemia (HP:0002155) | 3.74448895 |
| 11 | Ketosis (HP:0001946) | 3.71541015 |
| 12 | Increased connective tissue (HP:0009025) | 3.69203181 |
| 13 | Complement deficiency (HP:0004431) | 3.65445757 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.56244808 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.40408190 |
| 16 | Vascular tortuosity (HP:0004948) | 3.40238073 |
| 17 | Hyperammonemia (HP:0001987) | 3.38383184 |
| 18 | Xanthomatosis (HP:0000991) | 3.31575461 |
| 19 | Difficulty running (HP:0009046) | 3.30493594 |
| 20 | Arterial tortuosity (HP:0005116) | 3.29221648 |
| 21 | Joint hemorrhage (HP:0005261) | 3.25218789 |
| 22 | Broad metatarsal (HP:0001783) | 3.16257860 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.14853265 |
| 24 | Rhabdomyolysis (HP:0003201) | 3.14753314 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.06911022 |
| 26 | Hyperglycinemia (HP:0002154) | 3.03250540 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.95758230 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 2.93664021 |
| 29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.93664021 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 2.93287200 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.90104273 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.86390180 |
| 33 | Lymphangioma (HP:0100764) | 2.83018160 |
| 34 | Hydroxyprolinuria (HP:0003080) | 2.81479084 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.81479084 |
| 36 | Epidermoid cyst (HP:0200040) | 2.80439435 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.74724557 |
| 38 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.74441264 |
| 39 | Right ventricular cardiomyopathy (HP:0011663) | 2.72917529 |
| 40 | Cervical subluxation (HP:0003308) | 2.65775968 |
| 41 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.62218029 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.61681043 |
| 43 | Lipoatrophy (HP:0100578) | 2.58040121 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.57099150 |
| 45 | Shallow orbits (HP:0000586) | 2.48780942 |
| 46 | Polycythemia (HP:0001901) | 2.47233981 |
| 47 | Abnormality of complement system (HP:0005339) | 2.46168771 |
| 48 | Exercise-induced muscle cramps (HP:0003710) | 2.45978895 |
| 49 | Myocardial infarction (HP:0001658) | 2.45635761 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.44075854 |
| 51 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44063432 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.43988993 |
| 53 | Abnormality of carpal bone ossification (HP:0006257) | 2.43495587 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43286902 |
| 55 | Increased purine levels (HP:0004368) | 2.43020618 |
| 56 | Hyperuricemia (HP:0002149) | 2.43020618 |
| 57 | Insulin resistance (HP:0000855) | 2.42432799 |
| 58 | Prolonged partial thromboplastin time (HP:0003645) | 2.41955655 |
| 59 | Overgrowth (HP:0001548) | 2.41570919 |
| 60 | Bone cyst (HP:0012062) | 2.37975810 |
| 61 | Aortic aneurysm (HP:0004942) | 2.37811424 |
| 62 | Protrusio acetabuli (HP:0003179) | 2.35870856 |
| 63 | Hematochezia (HP:0002573) | 2.35378593 |
| 64 | Nausea (HP:0002018) | 2.34571397 |
| 65 | Esophageal varix (HP:0002040) | 2.31791070 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.26462902 |
| 67 | Proximal tubulopathy (HP:0000114) | 2.26369244 |
| 68 | Hyperglycemia (HP:0003074) | 2.25542153 |
| 69 | Skin nodule (HP:0200036) | 2.25365436 |
| 70 | Asymmetric septal hypertrophy (HP:0001670) | 2.23804150 |
| 71 | Back pain (HP:0003418) | 2.22452630 |
| 72 | Soft skin (HP:0000977) | 2.22020975 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.21849423 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.20624660 |
| 75 | Wormian bones (HP:0002645) | 2.18953399 |
| 76 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.18377385 |
| 77 | Gout (HP:0001997) | 2.17406274 |
| 78 | Striae distensae (HP:0001065) | 2.17405736 |
| 79 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17139367 |
| 80 | Limited hip movement (HP:0008800) | 2.15697698 |
| 81 | Sudden death (HP:0001699) | 2.15451139 |
| 82 | Spinal rigidity (HP:0003306) | 2.13724605 |
| 83 | Glomerulonephritis (HP:0000099) | 2.13702527 |
| 84 | Ventricular tachycardia (HP:0004756) | 2.11144120 |
| 85 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.10743460 |
| 86 | Muscle stiffness (HP:0003552) | 2.10481700 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.10339764 |
| 88 | Growth hormone excess (HP:0000845) | 2.10280343 |
| 89 | Skull defect (HP:0001362) | 2.10183211 |
| 90 | Muscle fiber inclusion bodies (HP:0100299) | 2.09072446 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.08831375 |
| 92 | Abnormal cartilage morphology (HP:0002763) | 2.08514296 |
| 93 | Abnormality of the calf musculature (HP:0001430) | 2.07510127 |
| 94 | Neck muscle weakness (HP:0000467) | 2.07250015 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06501919 |
| 96 | Mitral stenosis (HP:0001718) | 2.06109987 |
| 97 | Facial diplegia (HP:0001349) | 2.05326199 |
| 98 | Calf muscle hypertrophy (HP:0008981) | 2.03023270 |
| 99 | Premature rupture of membranes (HP:0001788) | 2.02822083 |
| 100 | Ectopia lentis (HP:0001083) | 2.02707589 |
| 101 | Aneurysm (HP:0002617) | 2.02363930 |
| 102 | Aortic dissection (HP:0002647) | 2.01862810 |
| 103 | Nemaline bodies (HP:0003798) | 2.01810479 |
| 104 | Visceral angiomatosis (HP:0100761) | 1.98465813 |
| 105 | Metabolic acidosis (HP:0001942) | 1.98297233 |
| 106 | Hypoplasia of the iris (HP:0007676) | 1.97861962 |
| 107 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97052337 |
| 108 | Atrioventricular block (HP:0001678) | 1.95959914 |
| 109 | Potter facies (HP:0002009) | 1.95490880 |
| 110 | Facial shape deformation (HP:0011334) | 1.95490880 |
| 111 | Rectal prolapse (HP:0002035) | 1.95488691 |
| 112 | Wrist flexion contracture (HP:0001239) | 1.95034319 |
| 113 | Vascular calcification (HP:0004934) | 1.94280049 |
| 114 | Pulmonary artery stenosis (HP:0004415) | 1.93519257 |
| 115 | Abnormality of the acetabulum (HP:0003170) | 1.91002934 |
| 116 | Infantile muscular hypotonia (HP:0008947) | 1.89040605 |
| 117 | Blue sclerae (HP:0000592) | 1.88872676 |
| 118 | Neonatal death (HP:0003811) | 1.87876729 |
| 119 | Abnormal ossification of hand bones (HP:0005921) | 1.86772309 |
| 120 | Abnormal delivery (HP:0001787) | 1.85972801 |
| 121 | Bundle branch block (HP:0011710) | 1.85937386 |
| 122 | Coxa vara (HP:0002812) | 1.85186106 |
| 123 | Ankle contracture (HP:0006466) | 1.85049693 |
| 124 | Myotonia (HP:0002486) | 1.84584088 |
| 125 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.84046578 |
| 126 | Hypokalemic alkalosis (HP:0001949) | 1.83810323 |
| 127 | Hemangiomatosis (HP:0007461) | 1.83148110 |
| 128 | Hip contracture (HP:0003273) | 1.83131275 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.82801268 |
| 130 | Portal hypertension (HP:0001409) | 1.82653360 |
| 131 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81577008 |
| 132 | Pancreatitis (HP:0001733) | 1.81397865 |
| 133 | Abnormal hand bone ossification (HP:0010660) | 1.81263931 |
| 134 | Abnormality of serum amino acid levels (HP:0003112) | 1.81213462 |
| 135 | Mitral valve prolapse (HP:0001634) | 1.81029794 |
| 136 | Dilated cardiomyopathy (HP:0001644) | 1.79487294 |
| 137 | Hypoglycemic seizures (HP:0002173) | 1.78650960 |
| 138 | Venous abnormality (HP:0002624) | 1.77984680 |
| 139 | Menorrhagia (HP:0000132) | 1.77981133 |
| 140 | Hepatocellular carcinoma (HP:0001402) | 1.77424045 |
| 141 | Ovoid vertebral bodies (HP:0003300) | 1.76278630 |
| 142 | Round ear (HP:0100830) | 1.76028285 |
| 143 | Delayed CNS myelination (HP:0002188) | 1.75869462 |
| 144 | Wide anterior fontanel (HP:0000260) | 1.75592102 |
| 145 | Cavernous hemangioma (HP:0001048) | 1.75459172 |
| 146 | Cerebral hemorrhage (HP:0001342) | 1.75148485 |
| 147 | Prenatal maternal abnormality (HP:0002686) | 1.74810758 |
| 148 | Dilatation of the ascending aorta (HP:0005111) | 1.74736841 |
| 149 | Systemic lupus erythematosus (HP:0002725) | 1.74428717 |
| 150 | Abnormal atrioventricular conduction (HP:0005150) | 1.74416643 |
| 151 | Vomiting (HP:0002013) | 1.74321322 |
| 152 | Lethargy (HP:0001254) | 1.74273347 |
| 153 | Abnormality of nucleobase metabolism (HP:0010932) | 1.73044914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.75589440 |
| 2 | TRIB3 | 4.01825114 |
| 3 | CAMK1D | 3.67345902 |
| 4 | BCKDK | 3.59056032 |
| 5 | SIK1 | 3.12705644 |
| 6 | KDR | 2.74279816 |
| 7 | CAMK1G | 2.66861553 |
| 8 | TGFBR2 | 2.47621136 |
| 9 | RIPK1 | 2.46002760 |
| 10 | PDK3 | 2.37308721 |
| 11 | PDK4 | 2.37308721 |
| 12 | TTN | 2.28242651 |
| 13 | AKT3 | 2.23930454 |
| 14 | LATS1 | 2.19690235 |
| 15 | INSRR | 2.11125350 |
| 16 | ERN1 | 1.94633632 |
| 17 | LMTK2 | 1.93451859 |
| 18 | OBSCN | 1.91937171 |
| 19 | PDK2 | 1.90970433 |
| 20 | EEF2K | 1.81124327 |
| 21 | PDGFRA | 1.64876489 |
| 22 | FRK | 1.63297637 |
| 23 | WNK4 | 1.61601627 |
| 24 | FGFR2 | 1.57667172 |
| 25 | EPHB2 | 1.56360436 |
| 26 | PRKAA2 | 1.55748982 |
| 27 | MST1R | 1.55192155 |
| 28 | FGFR4 | 1.53385215 |
| 29 | PKN2 | 1.52612679 |
| 30 | FGFR3 | 1.47615170 |
| 31 | MYLK | 1.45691793 |
| 32 | PHKG1 | 1.41332351 |
| 33 | PHKG2 | 1.41332351 |
| 34 | PIK3CA | 1.27460273 |
| 35 | NEK9 | 1.26022839 |
| 36 | DDR2 | 1.21920947 |
| 37 | STK38L | 1.20666496 |
| 38 | MAPKAPK3 | 1.15406216 |
| 39 | ICK | 1.12606131 |
| 40 | FER | 1.10266561 |
| 41 | MAP2K3 | 1.09647743 |
| 42 | PTK6 | 1.05441374 |
| 43 | CDK6 | 1.01753393 |
| 44 | PTK2B | 1.00641996 |
| 45 | DMPK | 0.96587320 |
| 46 | NLK | 0.92473318 |
| 47 | EPHA2 | 0.90118442 |
| 48 | TGFBR1 | 0.89631566 |
| 49 | NTRK1 | 0.88639690 |
| 50 | PRKAA1 | 0.88574142 |
| 51 | MET | 0.87699816 |
| 52 | WNK3 | 0.87000611 |
| 53 | STK3 | 0.85045204 |
| 54 | MAP3K7 | 0.79806064 |
| 55 | JAK1 | 0.78970447 |
| 56 | CAMK1 | 0.77859372 |
| 57 | CDK9 | 0.76533131 |
| 58 | STK39 | 0.75860122 |
| 59 | OXSR1 | 0.75754822 |
| 60 | PINK1 | 0.74190654 |
| 61 | LATS2 | 0.73374408 |
| 62 | MAPK12 | 0.71657820 |
| 63 | CDC42BPA | 0.68874094 |
| 64 | MAP2K1 | 0.67142699 |
| 65 | EPHB1 | 0.66766096 |
| 66 | PDPK1 | 0.65961495 |
| 67 | PRKD1 | 0.65825415 |
| 68 | JAK2 | 0.65561131 |
| 69 | MAP3K3 | 0.65065765 |
| 70 | PRKCH | 0.64306783 |
| 71 | GSK3A | 0.63784048 |
| 72 | PDGFRB | 0.63381895 |
| 73 | ERBB4 | 0.63204627 |
| 74 | TRPM7 | 0.62166326 |
| 75 | PIK3CG | 0.61268029 |
| 76 | MTOR | 0.58499076 |
| 77 | MARK2 | 0.58425857 |
| 78 | TYRO3 | 0.58005016 |
| 79 | MAP3K6 | 0.57499017 |
| 80 | IGF1R | 0.56977705 |
| 81 | PAK4 | 0.56865043 |
| 82 | MAPK11 | 0.56392946 |
| 83 | FGFR1 | 0.56257148 |
| 84 | RET | 0.55396886 |
| 85 | MAP2K4 | 0.54610955 |
| 86 | PRKD3 | 0.54557397 |
| 87 | MAPK4 | 0.54316660 |
| 88 | FLT3 | 0.49237075 |
| 89 | SGK3 | 0.48165581 |
| 90 | PRKG2 | 0.46744089 |
| 91 | MAPK7 | 0.46277553 |
| 92 | PRKG1 | 0.43965363 |
| 93 | NEK1 | 0.43049268 |
| 94 | PRKACG | 0.42584281 |
| 95 | PAK2 | 0.42547255 |
| 96 | AKT2 | 0.40566697 |
| 97 | WNK1 | 0.40373781 |
| 98 | LRRK2 | 0.39466131 |
| 99 | PDK1 | 0.39022787 |
| 100 | PTK2 | 0.38219510 |
| 101 | CSK | 0.37965864 |
| 102 | TESK1 | 0.35915525 |
| 103 | IRAK3 | 0.35762866 |
| 104 | STK38 | 0.34648850 |
| 105 | ILK | 0.33597316 |
| 106 | EPHA3 | 0.33259304 |
| 107 | STK24 | 0.32728482 |
| 108 | ROCK1 | 0.31723776 |
| 109 | SGK223 | 0.31320844 |
| 110 | SGK494 | 0.31320844 |
| 111 | GRK5 | 0.31264518 |
| 112 | BMX | 0.30895568 |
| 113 | ABL2 | 0.30659088 |
| 114 | INSR | 0.29925814 |
| 115 | GRK1 | 0.29688220 |
| 116 | PRKCE | 0.29198006 |
| 117 | CDK4 | 0.29119842 |
| 118 | CAMK4 | 0.27074877 |
| 119 | RPS6KA2 | 0.26762220 |
| 120 | PAK3 | 0.26544789 |
| 121 | SGK2 | 0.26517911 |
| 122 | ADRBK1 | 0.26114350 |
| 123 | SRC | 0.25340124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.85661052 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.40526809 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.36695978 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.30830198 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.10350990 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.05842526 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.81507273 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.50637793 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.45406755 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.43012324 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42536628 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07057864 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.01976696 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98124521 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.94696048 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93348436 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88417136 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.82934593 |
| 19 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.80820924 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76906076 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.72028454 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60035740 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58202254 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57653846 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.55637427 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49222711 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43144917 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42847131 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33151479 |
| 30 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.29786706 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29701170 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28719788 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21856554 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21626453 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.18089411 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16792098 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16649892 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10346989 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08191827 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.07596892 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06918492 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06122096 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 1.04034365 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96755986 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.90906712 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89539712 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82323886 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80621969 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80451701 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78182851 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78007031 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77907921 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77061388 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75802921 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75784193 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75425015 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71732390 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 0.71012263 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64741459 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64312966 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63579629 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63124769 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60913819 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60519669 |
| 65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57894687 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57379418 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53302863 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51802905 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50607700 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47308921 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47076820 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46939970 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.46647202 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46244258 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45209410 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43463295 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42210583 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42162140 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41764489 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40937340 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40152577 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39978961 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.39576678 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39375390 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37212657 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.37186097 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37033800 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36151680 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35920370 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.35774825 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35737928 |
| 92 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35237939 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.34838363 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34417211 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33423112 |
| 96 | Malaria_Homo sapiens_hsa05144 | 0.32560573 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.32519052 |
| 98 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32034268 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30142551 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29820605 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29793015 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27517463 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27192807 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27111671 |
| 105 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.26541094 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24898553 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.24688536 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23751123 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22775666 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22366256 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20721834 |
| 112 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20616223 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20190383 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19665104 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.19542331 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18602871 |
| 117 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17826199 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14541550 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13395113 |
| 120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.11855703 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.11732504 |

